Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus aspirin plus clopidogrel after uncomplicated TAVI
2018-000608-40Phase 4Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in aortic stenosis (AS) comparing Aspirin with Aspirin + clopidogrel (2 arms). Primary endpoint: Composite of death, stroke/systemic embolism, rehospitalization for clinical deterioration due to thrombotic prosthetic dysfunction, or BARC type 2, 3, or 5 bleeding at 6 months. Started Sep 2021; status: terminated.
02
Drugs
aspirinclopidogrel
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2018-000608-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000608-40.